REBIF (interferon beta-1a) – a interferon beta-1a product commonly used to treat relapsing forms of multiple sclerosis. The specific mechanism by which interferon beta-1a exerts its effects in the treatment of multiple sclerosis has not been fully elucidated. FDA approved uses: Rebif is indicated for the treatment of patients with relapsing forms of multiple sclerosis […]
TRICOR (fenofibrate) – a peroxisome proliferator receptor alpha (PPARα) activator commonly used to treat certain lipid disorders. FDA approved uses: TriCor is indicated as an adjunct to diet – To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia; For treatment of adult […]
LIDODERM (lidocaine patch 5%) – topical patch formulation of lidocaine commonly used to treat neuropathic pain. Lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses. The penetration of lidocaine into intact skin after application of LIDODERM is […]
ANDROGEL (testosterone gel) – a topical testosterone replacement product commonly for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. AndroGel exerts its effect by delivering physiologic amounts of testosterone, producing circulating testosterone concentrations that approximate normal concentrations seen in healthy men. FDA approved uses: Androgel is indicated for […]